David Bae, M.D.
NPI 1053706325ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· New York, NY
Internal Medicine, Advanced Heart Failure and Transplant Cardiology (M.D.) in New York, New York, trained at State University of Ny Upstate Medical University (class of 2015). Their prescriptions cost Medicare Part D more than their services did: $1,143,383 for 354 claims, against $77,758 paid for services in 2024. Abbott Laboratories was the largest of 9 companies reporting payments in 2025, $446.36 in all, mostly food and beverage.
Overview
| NPI | 1053706325 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Apr 2, 2015 |
| Last updated in NPPES | May 3, 2022 |
| Certified by provider | May 3, 2022 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Advanced Heart Failure and Transplant Cardiology Primary | 207RA0001X | 308918 | NY |
| Internal Medicine, Cardiovascular Disease | 207RC0000X | 308918 | NY |
| Student in an Organized Health Care Education/Training Program | 390200000X | — | — |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Advanced Heart Failure and Transplant Cardiology (NY) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 208 |
|---|---|
| Services billed | 684 across 24 procedure codes |
| Paid by Medicare | $77,758 |
Part D prescriptions in 2024
| Prescriptions (claims) | 354 · 860 30-day fills |
|---|---|
| Patients | 79 |
| Total drug cost | $1,143,383 |
| Generic share | 60% of claims |
Education and affiliations
| Medical school | State University of Ny Upstate Medical University |
|---|---|
| Graduation year | 2015 |
| Medicare specialty | Advanced Heart Failure And Transplant Cardiology |
Medical group
- Trustees of Columbia University in the City of New YorkNew York, NY · 2,296 clinicians
Hospital affiliation
- New York-Presbyterian HospitalNew York, NY
Industry payments (Open Payments)
- 2025$446.36 · 14 payments from 9 companies
- 2024$1,026 · 15 payments from 5 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Abbott Laboratories | $148.56 | 1 |
| Astrazeneca Pharmaceuticals LP | $68.40 | 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $65.37 | 3 |
| Ceribell, Inc. | $47.58 | 1 |
| Alnylam Pharmaceuticals Inc. | $35.27 | 1 |
What the 2025 payments were for
- Food and Beverage$446.36 · 14 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York
- 1124333182
- 1568717692
- 1740561133
- 1841459997
- 1063918456
- 1225115082
- 1356604607
- 1376905380
- 1649563073
- 1336226810
- 1528188190
- 1073994208
All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New York →